OMARIDIN™ has unique low and mid-frequency vibrations that can affect brain waves…
When people first listen to OMARIDIN™, they sometimes describe a mild sense of discomfort or “sensory shock.”
This reaction is not a flaw — it marks the brain’s first phase of adaptation to a new and complex acoustic environment.
At the beginning, the primary auditory cortex and amygdala respond with increased activity.
The brain tries to decode the unfamiliar signal — a sound with micro-resonances, phase interferences, and subtle fluctuations in amplitude.
This creates short-term tension and alertness — an evolutionary mechanism of protection.
Once the brain recognises there is no threat, regulatory centres — including the hypothalamus and autonomic nervous system — begin to stabilise physiological rhythms.
Heartbeat, breathing, and even micro-movements start to synchronise with the sound pattern.
Gradually, activity shifts toward the insula and prefrontal cortex, regions responsible for bodily awareness, calm focus, and emotional integration.
At this stage, internal dialogue quiets, and a state of coherence emerges.
The acoustic structure of OMARIDIN™ contains low- and mid-frequency components that interact with theta (4–8 Hz) and alpha (8–12 Hz) brainwave ranges — frequencies linked to regeneration, creativity, and balanced attention.
In essence, the initial “shock” is a neuroadaptive gateway — a brief activation that leads to synchronisation, resonance, and, ultimately, inner balance.
